Bicycle Therapeutics Plc ADR’s recent filing unveils that its Officer Thompson Travis Alvin acquired Company’s shares for reported $28224.0 on Jan 02 ’25. In the deal valued at $14.00 per share,2,016 shares were bought.
Then, Young Alethia bought 1,395 shares, generating $19,530 in total proceeds.
Before that, Arroyo Santiago bought 4,943 shares. Bicycle Therapeutics Plc ADR shares valued at $69,202 were divested by the Officer at a price of $14.00 per share.
Stephens initiated its Bicycle Therapeutics Plc ADR [BCYC] rating to an Equal-weight in a research note published on November 08, 2024; the price target was $25. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who began to cover the stock in early September with a ‘”an Outperform”‘ rating. B. Riley Securities also remained covering BCYC and has decreased its forecast on August 07, 2024 with a “Neutral” recommendation from previously “Buy” rating. B. Riley Securities revised its rating on September 11, 2023. It rated BCYC as “a Buy” which previously was an “a Neutral”.
Price Performance Review of BCYC
On Friday, Bicycle Therapeutics Plc ADR [NASDAQ:BCYC] saw its stock jump 3.69% to $14.89. Over the last five days, the stock has gained 1.99%. Bicycle Therapeutics Plc ADR shares have risen nearly 6.36% since the year began. Nevertheless, the stocks have fallen -14.13% over the past one year. While a 52-week high of $28.67 was reached on 01/03/25, a 52-week low of $12.17 was recorded on 01/02/25. SMA at 50 days reached $19.99, while 200 days put it at $22.38.
Levels Of Support And Resistance For BCYC Stock
The 24-hour chart illustrates a support level at 14.50, which if violated will result in even more drops to 14.10. On the upside, there is a resistance level at 15.24. A further resistance level may holdings at 15.58. The Relative Strength Index (RSI) on the 14-day chart is 34.98, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.21, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 51.52%. Stochastics %K at 31.05% indicates the stock is a holding.
How much short interest is there in Bicycle Therapeutics Plc ADR?
A steep rise in short interest was recorded in Bicycle Therapeutics Plc ADR stocks on 2024-12-13, dropping by 91048.0 shares to a total of 3.43 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 3.52 million shares. There was a decline of -2.65%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on August 31, 2022 when Cowen began covering the stock and recommended ‘”an Outperform”‘ rating .
